Insider · SEC Form 4 filer

James Healy

Past buys: 1 of 3 beat

Companies

Where they file as an insider

Rapport Therapeutics (RAPP) Director Latest filing Oct 28, 2026
Seaport Therapeutics (SPTX) Director Latest filing May 4, 2026
Y-mAbs Therapeutics (YMAB) Director Latest filing Sep 16, 2025
Natera (NTRA) Director Latest filing Apr 25, 2025
BioAge Labs (BIOA) Director Latest filing Sep 27, 2024
Karuna Therapeutics (KRTX) Director Latest filing Mar 18, 2024
ArriVent Biopharma (AVBP) Director Latest filing Jan 30, 2024

Track record

Did their buys beat the typical stock?

Open-market buys27
Quarters checked 6 months later3
Beat the typical stock 1 of 3
Quarters too new to check1

1 of 3 checked quarters beat the typical stock. A past record is data, not a forecast.

Rapport Therapeutics (RAPP) Bought Oct 28, 2026 · $20.4M · 969,480 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
BioAge Labs (BIOA) Bought Sep 27, 2024 · $12M · 666,665 shares Not counted Not counted. We have no fund price for this stock on both Sep 30, 2024 and Mar 31, 2025.
Rapport Therapeutics (RAPP) Bought Jul 1, 2024 · $1.08M · 44,032 shares Behind typical Sep 30, 2024 $20.48 → Mar 31, 2025 $10.03 · −51.0% (typical stock −7.5%)
Rapport Therapeutics (RAPP) Bought Jun 10, 2024 · $9.5M · 558,824 shares Behind typical Jun 30, 2024 $23.26 → Dec 31, 2024 $17.74 · −23.7% (typical stock +3.9%)
ArriVent Biopharma (AVBP) Bought Jan 30, 2024 · $8M · 444,444 shares Beat typical Mar 31, 2024 $17.86 → Sep 30, 2024 $23.50 · +31.6% (typical stock +3.2%)

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist